Publication in Nature Genetics on testicular cancer susceptibility
Rolf Skotheim (photo) is the site responsible in Oslo, and says that across all types of cancer, testicular cancer is now the type for which known susceptibility genes explain the largest fraction the genetic risk.
PhD student Deeqa Ahmed profiled in Uniforum
Research by PhD student Deeqa Ahmed and colleagues at the Department of Cancer Prevention may provide improved colorectal cancer diagnostics. Identification of a set of biomarkers that has been licensed by Oxford Gene Technology may lead to new tests for early cancer detection.
Full story in Norwegian.
Awards from Oslo University Hospital to outstanding researchers
New group leader Guro E Lind received "Early Career award" from Oslo University hospital. Post doc Anita Sveen and colleagues were honored for "Excellent original article".
Research based innovation
Department of Cancer Prevention receives funding from the Norwegian Research Council from the FORNY2020 and BIOTEK2021 programmes for innovation projects on colorectal cancer. Development of prognostic and predictive markers for CRC is led by professor Ragnhild A. Lothe with Dr.s Rolf I. Skotheim, Guro E. Lind and professor Arild Nesbakken as active partners.
Project presentation in Norwegian
Link til Dept Cancer prevention
Link til CCB
Comprehensive review on molecular biology of germ cell tumors of the ovary
Drs Sigrid Marie Kraggerud, Christina Høi-Hansen and Sharmini Alagaratnam publish in Endrocrine Reviews, the highest ranked journal in the category of Endocrinology and metabolism with IF of 19.9.
Group leader Guro E. Lind invited to Ekko, NRK P2
Monday the 9th of April, Lind was invited to the radio program “Ekko” to talk about blood based testing for early detection of colorectal cancer.
The program (in Norwegian) can be heard here: nrk_ekko_-_et_aktuelt_samfunnsprogram_2013-0408-1238_6350102183.mp3
Ragnhild A. Lothe appointed "Innovator of the month" by Helse Sør-Øst for March 2013
For the month of March 2013, this honor goes to professor Ragnhild A.Lothe, Genetics group, Department of Cancer Prevention at the Institute for Cancer Research.
From the web pages of South-Eastern Norway Regional Health Authority (in Norwegian):
Innovator of the month
Alagaratnam article published in Stem Cells and Development
A gene signature distinguishing the two cell types was identified, which included a number of cancer relevant and pluripotency genes. NR5A2 is an especially intriguing candidate given its role in the WNT-signalling pathway, which is often disrupted in cancer, and particularly so in colorectal cancer.
Link to article
Shiva Dahal-Koirala awarded Master’s degree
Scientists at Department of Cancer Prevention awarded prize for Excellent Research Article
A study carried out at Edward Leithe’s project group at Department of Cancer Prevention has been awarded a prize for Excellent Research Article by the Oslo University Hospital. The prize was presented on Friday 26th October and carries an award of 50,000 kr.
Print this page [1263 visits]
